While tuberculosis (TB) is a risk factor in HIV-1-infected individuals, the mechanisms by which Mycobacterium tuberculosis worsens HIV-1 pathogenesis remain poorly understood. Recently, we showed that HIV-1 infection and spread are exacerbated in macrophages exposed to TB-associated microenvironments due to tunneling nanotube (TNT) formation. To identify molecular factors associated with TNT function, we performed a transcriptomic analysis in these macrophages, and revealed the up-regulation of the lectin receptor Siglec-1. We demonstrate Siglec-1 expression depends on TB-mediated production of type I interferon.
INTRODUCTION
Co-infection with Mycobacterium tuberculosis (Mtb) and the human immunodeficiency virus (HIV-1), the agents of tuberculosis (TB) and acquired immunodeficiency syndrome (AIDS), respectively, is a major health issue. Indeed, TB is the most common illness in HIV-1-infected individuals, about 55% of TB notified patients are also infected with HIV-1, and about a fifth of the TB death toll occurs in HIV-1 co-infected individuals (WHO health report 2017) . Clinical studies evidence a synergy between these two pathogens, which is associated with a spectrum of aberration in immune function (Esmail et al., 2018) . Yet, while progress has been made towards understanding how HIV-1 enhances Mtb growth and spread, the mechanisms by which Mtb exacerbates HIV-1 infection require further investigation (Bell and Noursadeghi, 2018; Deffur et al., 2013; Diedrich and Flynn, 2011) .
Besides CD4 + T cells, macrophages are infected by HIV-1 in humans and by the simian immunodeficiency virus (SIV), the most closely related lentivirus to HIV, in non-human primates (NHP) (Cribbs et al., 2015; Rodrigues et al., 2017) . Recently, using a humanized mouse model, macrophages were shown to sustain HIV-1 infection and replication, even in the absence of T cells (Honeycutt et al., 2017; Honeycutt et al., 2016) . This is in line with several studies characterizing tissue macrophages, such as alveolar, microglia and gut macrophages, as reservoirs in HIV-1 patients undergoing antiretroviral therapy (Ganor et al., 2019; Jambo et al., 2014; Mathews et al., 2019; Sattentau and Stevenson, 2016) .
Macrophages are key host cells for Mtb (O'Garra et al., 2013; VanderVen et al., 2016) . We recently reported the importance of macrophages in HIV-1 exacerbation within the TB coinfection context (Souriant et al., 2019) . Using relevant in vitro and in vivo models, we showed that TB-associated microenvironments activate macrophages towards an M(IL-10) profile, distinguished by a CD16 + CD163 + MerTK + phenotype. Acquisition of this phenotype is dependent on the IL-10/STAT3 signaling pathway (Lastrucci et al., 2015) . M(IL-10) macrophages are highly susceptible not only to Mtb infection (Lastrucci et al., 2015) , but also to HIV-1 infection and spread (Souriant et al., 2019) . At the functional level, we demonstrated that TB-associated microenvironments stimulate the formation of tunneling nanotubes (TNT), membranous channels connecting two or more cells over short to long distances above substrates. TNT are subdivided in two classes based on their thickness and cytoskeleton composition: "thin" TNT (<0.7 μm in diameter) containing F-actin, and "thick" TNT (>0.7 μm in diameter) are enriched in F-actin and microtubules (MTs) (Souriant et al., 2019) . Thick TNT are functionally distinguished by the transfer of large organelles, such as lysosomes and mitochondria (Dupont et al., 2018; Eugenin et al., 2009; Hashimoto et al., 2016) . While the contribution for each TNT class to HIV-1 pathogenesis has not been explored (Dupont et al., 2018; Eugenin et al., 2009; Hashimoto et al., 2016) , we reported that total inhibition of TNT formation in M(IL-10) macrophages resulted in the abrogation of HIV-1 exacerbation induced by Mtb (Souriant et al., 2019) . Factors influencing TNT function in M(IL-10) macrophages remain unknown at large.
In this study, global mapping of the M(IL-10) macrophage transcriptome revealed Siglec-1 (CD169, or sialoadhesin) as a potential factor responsible for HIV-1 dissemination in the coinfection context with TB. As a type I transmembrane lectin receptor, Siglec-1 possesses a large extracellular domain composed of 17 immunoglobulin-like domains, including the N-terminal V-set domain, which allows the trans recognition of terminal 2,3-linked sialic acid residues in O-and N-linked glycans and glycolipids, such as those surface-exposed in HIV-1 and SIV particles (Izquierdo-Useros et al., 2012a; Puryear et al., 2012) . While Siglec-1 has yet to be implicated in the TB context, it is clearly involved in the pathogenesis of HIV-1, SIV and other retroviruses (Martinez-Picado et al., 2017) . Siglec-1 is mainly expressed in myeloid cells (macrophages and dendritic cells) and participates in HIV-1 transfer from myeloid cells to T cells, as well as in the initiation of virus-containing compartment (VCC) formation in macrophages (Izquierdo-Useros et al., 2012a; Izquierdo-Useros et al., 2012b; Puryear et al., 2013; Puryear et al., 2012) , and in the viral dissemination in vivo (Akiyama et al., 2017; Izquierdo-Useros et al., 2012a; Sewald et al., 2015) . Indeed, HIV-1 and other retroviruses have evolved the capacity to hijack the immune surveillance and housekeeping immunoregulatory functions of Siglec-1 (Izquierdo-Useros et al., 2014; O'Neill et al., 2013) . Here, we investigate how Siglec-1 expression is induced by TB, and the role it has in the capture and transfer of HIV-1 by TB-induced M(IL-10) macrophages, in particular in the context of TNT.
RESULTS

Tuberculosis-associated microenvironments induce Siglec-1 in macrophages
TB-induced M(IL-10) macrophages are highly susceptible to HIV-1 infection and spread (Souriant et al., 2019) . To assess the global gene expression landscape in these cells, we performed a genome-wide transcriptome analysis (GEO submission GSE139511). To this end, we employed our published in vitro model (Lastrucci et al., 2015) , which relies on the use of conditioned medium from either mock-(cmCTR) or Mtb-infected (cmMTB) human macrophages. As we described and observed before and herein, cmMTB-treated cells were positive for the M(IL-10) markers (CD16 + CD163 + MerTK + and phosphorylated STAT3), and displayed a high rate of HIV-1 infection, as compared to those treated with cmCTR (Lastrucci et al., 2015) . A distinct 60 gene-transcript signature was defined in cmMTB-treated cells, using a combination of the expression level, statistical filters and hierarchical clustering; 51 genes were up-regulated and 9 genes were down-regulated in cmMTB-compared to cmCTR-treated cells (Figure 1A) . We compared expression data of cmMTB-and cmCTR-treated cells to public genesets available from MSigDB (Broad Institute) using the gene set enrichment analysis (GSEA) algorithm (Subramanian et al., 2005) . As shown in Figure S1A , a significant fraction of genes that were up-regulated in response to interferon (IFN) type I (e.g. IFN) and II (i.e. IFN), were also found, as a group, significantly up-regulated in cmMTB-treated cells in comparison to control samples (FDR q-value: < 10E-3). IFN-stimulated genes (ISG) usually exert antiviral activities (McNab et al., 2015; Schneider et al., 2014) and cannot be inferred as obvious candidates to facilitate HIV-1 infection. However, among this ISG signature, the up-regulation of Siglec-1 (7.4-fold, adjusted p value of 0.0162) in cmMTB-treated cells captured our attention due to its known role in HIV-1 pathogenesis (Izquierdo-Useros et al., 2014; O'Neill et al., 2013) . We confirmed high Siglec-1 expression in cmMTB-treated macrophages at the mRNA ( Figure 1B ) and cell-surface protein ( Figure 1C , Figure S1B ) levels, which was superior to the level obtained in HIV-1-infected cells ( Figure S1C ). Particularly, cmMTB-treated macrophages displayed high density of Siglec-1 surface expression applying a quantitative FACS assay that determines the absolute number of Siglec-1 antibody binding sites per cell ( Figure 1D ).
These data indicate that Siglec-1 is highly expressed in human macrophages exposed to TBassociated microenvironments and potentially in the context of TB-HIV co-infection.
Siglec-1 + alveolar macrophage abundance correlates with pathology in co-infected primates
NHP has been an invaluable in vivo model to better understand the role of macrophages in SIV/HIV pathogenesis (Merino et al., 2017) . Considering Siglec-1 binds sialylated lipids present in the envelop of HIV-1 and SIV (Izquierdo-Useros et al., 2012a; Puryear et al., 2012) , we examined the presence of Siglec-1 positive alveolar macrophages in lung biopsies obtained from different NHP groups: (i) co-infected with Mtb (active or latent TB) and SIV, (ii) monoinfected with Mtb (active or latent TB), (iii) mono-infected with SIV, and (iv) healthy (Table S1, Figure S2A ) (Cai et al., 2015; Kuroda et al., 2018; Souriant et al., 2019) . Histological immunostaining confirmed the presence of Siglec-1 + alveolar macrophages in the lungs of healthy NHP , and revealed its significant increase in NHP mono-infected with either Mtb or SIV . Strikingly, we noticed a massive abundance of these cells in co-infected NHP . Concerning the overall abundance of Siglec-1 + leukocytes in lungs, we observed a significant increased in all infected NHP in comparison to healthy, with a higher tendency in active TB or co-infected NHP (Figure 1G and S2A) . In fact, the number of Siglec-1 + leukocytes correlated positively with the severity of NHP pathology ( Figure 1H , Table S2 ). Based on their cell morphology, localization in alveoli, and co-expression with the macrophage marker CD163 ( Figure S2A -C), Siglec-1 + cells were identified as alveolar macrophages.
Collectively, these data show that Siglec-1 is up-regulated in alveolar macrophages in the context of a retroviral co-infection with active TB.
Siglec-1 expression is dependent on TB-mediated type I IFN signaling
Siglec-1 is an ISG whose expression is induced by IFN-I in myeloid cells (Hartnell et al., 2001) . In addition to viral infection, IFN-I is also induced in TB and known to mainly play a detrimental role (McNab et al., 2015; Moreira-Teixeira et al., 2018) . Siglec-1 expression has not been described in the TB context or in co-infection with retroviruses such as SIV or HIV-1, therefore we assessed whether IFN-I stimulates Siglec-1 expression in TB-associated microenvironments. First, we found that cmMTB contains high amounts of IFN-I compared to cmCTR (Figure 2A ). Next, we showed that recombinant IFN- significantly increased Siglec-1 cell-surface expression in macrophages, close to the level induced by cmMTB ( Figure 2B ). Interestingly, we observed a modest, albeit significant, induction of Siglec-1 expression in cells treated with interleukin 10 (IL-10), a cytokine we have previously showed to be abundant in cmMTB (Lastrucci et al., 2015) and that renders macrophages highly susceptible to HIV-1 infection (Souriant et al., 2019) . However, IL-10 depletion had no effect on Siglec-1 expression by cmMTB-treated cells ( Figure 2C ). By contrast, blocking the IFN-I receptor (IFNAR2) during cmMTB treatment fully abolished expression of Siglec-1 ( Figure 2D ), indicating that IFN-I is the responsible factor for Siglec-1 up-regulation in cmMTB-treated cells.
IFN-I binding to IFNAR leads to the phosphorylation and nuclear translocation of the transcription factor STAT1, whose role is essential for transcription of ISG (Ivashkiv and Donlin, 2014) . We thus examined the status of STAT1 activation in co-infected NHP lung tissue. Histological staining of serial sections of co-infected lungs revealed that zones rich in Siglec-1 + leukocytes also exhibited positivity for nuclear phosphorylated STAT1 (pSTAT1) ( Figure 2E ), and the abundance of these two markers strongly correlated with the active status of TB in the different NHP groups ( Figure 2F ). Moreover, we found that the majority of Siglec-1 + alveolar macrophages were also positive for nuclear pSTAT1 in the infected NHP groups compared to healthy (Figure 2E and 2G) . In fact, there was a higher number of pSTAT1 + alveolar macrophages in TB-SIV co-infected lungs when compared to those from monoinfected NHP .
Altogether, these data demonstrate that Siglec-1 expression in human macrophages is controlled by IFN-I in a TB-associated microenvironment, and suggest the involvement of the IFN-I/STAT1/Siglec-1 axis in the pathogenesis of TB and co-infection with retroviruses.
Siglec-1 localization on thick TNT is associated with their length and HIV-1 cargo
TNT formation is responsible for the increase in HIV-1 spread between human macrophages in TB-associated microenvironments (Souriant et al., 2019) . To investigate whether Siglec-1 expression is involved in this process, we first examined its localization in the context of TNT formed by cmMTB-treated cells infected by HIV-1. We observed that Siglec-1 is localized exclusively on microtubule (MT)-positive thick TNT, and not on thin TNT ( Figure 3A and Movie 1). Semi-automatic quantification of hundreds of TNT showed that about 50% of thick TNT were positive for Siglec-1 ( Figure 3B and S3A). These TNT exhibited a greater length compared to those lacking Siglec-1 ( Figure 3C ). Importantly, unlike thin TNT, HIV-1 viral proteins are found mainly inside Siglec-1 + thick TNT ( Figure 3D -E and Movie 2). In addition, these thick TNT also contain large organelles such as mitochondria ( Figure 3F and S3B), another characteristic distinguishing thick from thin TNT (Dupont et al., 2018; Onfelt et al., 2006) . In general, we also noticed that the incidence of Siglec-1 + thick TNT between HIV-1 infected macrophages persisted for more than one week upon HIV-1 infection ( Figure S3C ), suggesting a high degree of stability for these TNT.
These findings reveal an exclusive localization of Siglec-1 on MT-positive thick TNT that correlates positively with a greater length and high cargo of HIV-1 and mitochondria, arguing for a functional capacity of Siglec-1 + TNT to transfer material to recipient cells over long distances.
TB-driven exacerbation of HIV-1 infection and spread in macrophages requires Siglec-1
To demonstrate a functional role for Siglec-1 in the susceptibility of macrophages to HIV-1 infection and spread induced by TB, Siglec-1 was depleted in cmMTB-treated cells by siRNAmediated gene silencing (Figure 4A and S4A) . While this depletion did not affect the total number of thick TNT ( Figure 4B and S4B), we observed a 2-fold shortening of thick TNT in cells lacking Siglec-1 when compared to control cells ( Figure 4C ). Then, we performed a viral uptake assay in these cells using HIV-1 Gag-eGFP virus-like particles (GFP VLP) lacking the viral envelope glycoprotein but bearing sialylated lipids that interact with Siglec-1 on myeloid cells (Izquierdo-Useros et al., 2012b; Puryear et al., 2013) . We consistently observed binding of VLP along Siglec-1 + thick TNT ( Figure S4C ). Yet, in the absence of Siglec-1, we noticed a significant reduction of VLP binding in comparison to control cells ( Figure S4D ). We confirmed this functional observation using a blocking monoclonal antibody against Siglec-1, showing that this receptor is involved in HIV-1 binding in cmMTB-treated cells ( Figure S4E ).
We then assessed the role of Siglec-1 in HIV-1 transfer between macrophages, as this receptor is also important for the transfer of the virus to CD4 + T cells, (Akiyama et al., 2015; Izquierdo-Useros et al., 2012a; Puryear et al., 2013) . We used an established co-culture system between cmMTB-treated macrophages that allows the transfer of the viral Gag protein from infected (donor, Gag + , red) to uninfected (recipient, CellTracker + , green) cells over 24 hours (Souriant et al., 2019 ) ( Figure S4F ). Of note, since Siglec-1 facilitates the infection of macrophages (Zou et al., 2011) , we used VSV-G pseudotyped viruses to avoid any effect on HIV-1 primo-infection. Like this, we ensured the viral content was equal in cells at the time of the co-culture despite the loss of Siglec-1 ( Figure S4G ). The siRNA-mediated depletion of Siglec-1 significantly diminished the capacity of cmMTB-treated macrophages to transfer HIV-1 to recipient cells ( Figure 4D ), indicating that this receptor is involved in TB-driven macrophage-to-macrophage viral spread (Souriant et al., 2019) . Intriguinly, there was a decreasing tendency for the capacity of Siglec-1-depleted cmMTB-treated macrophages to transfer mitochondria to recipient cells compared to controls ( Figure 4E and S4F), alluding to a possible defect in mechanisms involved in intercellular material transfer including through thick TNT (Torralba et al., 2016) . Remarkably, using replicative HIV-1 ADA strain ( Figure 4A ), we showed that silencing Siglec-1 expression in cmMTB-treated cells abolished the exacerbation of HIV-1 infection and production, as well as the enhanced formation of multinucleated giant cells ( Figures 4F-G) , which are pathological hallmarks of HIV-1 infection of macrophages (Verollet et al., 2015; Verollet et al., 2010) .
These results determine that TB-induced Siglec-1 expression plays a key part in HIV-1 uptake and efficient cell-to-cell transfer, resulting in the exacerbation of HIV-1 infection and production in M(IL-10) macrophages.
DISCUSSION
In this study, we investigated potential mechanisms by which Mtb exacerbates HIV-1 infection in macrophages, and uncovered a deleterious role for Siglec-1 in this process. These findings have different contributions to our understanding of this receptor in the synergy between Mtb and distinct retroviral infections, and also for TNT biology in host-pathogen interactions.
Our global transcriptomic approach revealed the up-regulation of Siglec-1, as part of an ISGsignature enhanced in macrophages exposed to a TB-associated microenvironment. Although pulmonary active TB has been characterized as an IFN-I-driven disease (Berry et al., 2010; McNab et al., 2015; Moreira-Teixeira et al., 2018) , there are no reports in the literature about a role for Siglec-1 in TB or in Mtb co-infection with retroviruses. Expression of Siglec-1 is restricted to myeloid cells except circulating monocytes , and is enhanced by IFN-I (Puryear et al., 2013; Rempel et al., 2008) and during HIV-1 infection (Pino et al., 2015) . In addition, human alveolar macrophages are distinguished from lung interstitial macrophages by Siglec-1 expression (Yu et al., 2016) . In this study, we determined that IFN-I present in TBassociated environments is responsible for Siglec-1 overexpression in human macrophages, which resembled that obtained in HIV-1-infected cells. While we saw a modest induction of Siglec-1 in macrophages upon IL-10 treatment, its depletion from the TB-associated microenvironment had no effect on Siglec-1 expression. This could be explained by the fact that IL-10 induces the autocrine production of IFN-I (Ziegler-Heitbrock et al., 2003) to indirectly modulate Siglec-1 expression in M(IL-10), which then contributes to the exacerbation of HIV-1 infection as we previously reported (Souriant et al., 2019) . In the context of the most closely related lentivirus to HIV, namely SIV, we not only confirmed the presence of Siglec-1 + alveolar macrophages in SIV-infected NHP, but also reported the high abundance of these cells in active TB and in co-infected NHP groups, when compared to healthy ones. Importantly, we associated the high abundance of Siglec-1 + leukocytes with the increase NHP pathological scores, and it correlated positively to the detection of pSTAT1 + macrophage nuclei in histological staining of serial sections of lung biopsies from co-infected NHP. This is in line with a recent report on the presence of IFN-I, IFNAR and different ISGs in alveolar and lung interstitial tissue from NHP with active TB (Mattila, 2019) , and with the fact that the in vivo expression of Siglec-1 is up-regulated early in myeloid cells after SIV infection and maintained thereafter in the pathogenic NHP model (Jaroenpool et al., 2007) . In TB-SIV coinfection, we hypothesized that IFN-I is not exerting the expected antiviral effect, but instead is concomitant with chronic immune activation and attenuated by the high expression of Siglec-1 in myeloid cells, as recently proposed in the HIV-1 context (Akiyama et al., 2017) . Altogether, these findings uncover the IFN-I/STAT1/Siglec-1 axis as a mechanism established by Mtb to exacerbate HIV-1 infection in myeloid cells, and call for the need to further investigate this signaling pathway in TB pathogenesis.
Another aspect worth highlighting is the impact that Siglec-1 expression has in the capture and transfer of HIV-1 by M(IL-10) macrophages, in particular in the context of TNT. First, we reported that Siglec-1 is located on MT-positive thick (and not on thin) TNT, correlating positively with increased length and HIV-1 cargo. To our knowledge, no receptor has been described so far to be present exclusively on thick TNT, making Siglec-1 an unprecedented potential marker for this subtype of TNT (Dupont et al., 2018) . Second, viral uptake assays demonstrated the functional capacity of Siglec-1, including on thick TNT, to interact with virallike particles bearing sialylated lipids; loss-of-function approaches showed Siglec-1 is important in the capture of these viral particles. Third, Siglec-1 depletion correlated with a decrease in thick TNT length, but had no effect in the total number of thick TNT. This suggests that, while the IFN-I/STAT1 axis is responsible for Siglec-1 expression in M(IL-10) macrophages, it does not contribute to TNT formation. This is line with our previous report where TNT formation induced by TB-associated microenvironments depends on the IL-10/STAT3 axis (Souriant et al., 2019) . Concerning the shortening of thick TNT length, we infer that it may reflect a fragile state due to an altered cell membrane composition in the absence of Siglec-1; TNT are known for their fragility towards light exposure, shearing force and chemical fixation (Rustom et al., 2004) . We hypothesize that the longer the TNT is, the more rigidity it requires to be stabilized. Cholesterol and lipids are known to increase membrane rigidity (Redondo-Morata et al., 2012) and are thought to be critical for TNT stability (Lokar et al., 2012; Thayanithy et al., 2014) . Thus, the presence of Siglec-1 in thick TNT may affect the cholesterol and lipid composition via the recruitment of GM1/GM3 glycosphingolipid-enriched microvesicles (Halasz et al., 2018) . In fact, TNT formation depends on GM1/GM3 ganglioside and cholesterol content (Kabaso et al., 2011; Lokar et al., 2012; Osteikoetxea-Molnar et al., 2016; Toth et al., 2017) . Since GM1 and GM3 glycosphingolipids are bona fide ligands for Siglec-1 (Puryear et al., 2013) , it is likely that Siglec-1 + thick TNT exhibit a higher lipid and cholesterol content, and hence an increase of membrane rigidity that favors the stability of longer TNT. Fourth, Siglec-1-depleted donor macrophages were less capable to transfer HIV-1, and to some extend mitochondria, to recipient cells. While infectious synapse and exososome release are mechanisms attributed to Siglec-1 that contribute to cell-to-cell transfer of HIV-1 (Bracq et al., 2018; Gummuluru et al., 2014; Izquierdo-Useros et al., 2014) , they accomplish so extracellularly. Here, we speculate that Siglec-1 participates indirectly in the intracellular HIV-1 transfer via TNT as a tunnel over long distance, suggesting that factors affecting TNT rigidity favor distal viral dissemination while ensuring protection against immune detection. Finally, the depletion of Siglec-1 abrogated the exacerbation of HIV-1 infection and production induced by TB in M(IL-10) macrophages. This is likely to result from an accumulative effect of deficient capture and transfer of HIV-1 in the absence of Siglec-1. However, these results do not discern the specific contribution of Siglec-1 to the cell-to-cell transmission of HIV-1 via TNT from that obtained through other mechanisms (Bracq et al., 2018) . Future studies will address whether the contribution of Siglec-1 to cell-to-cell transfer mechanisms has an impact in Mtb dissemination (Onfelt et al., 2006) .
In conclusion, our study identifies Siglec-1 as a key TB-driven factor for the exacerbation of HIV-1 infection in macrophages, and as a new potential therapeutic target to limit viral dissemination in the co-infection context. It also sheds light on yet another housekeeping function for Siglec-1 with the potential to be hijacked by pathogens including HIV-1, such as intercellular communication facilitated by TNT. We argue that Siglec-1 localization on thick TNT has a physiological significance to macrophage biology in health and disease.
MATERIAL AND METHODS
Human Subjects
Monocytes from healthy subjects were provided by Etablissement Français du Sang (EFS), Toulouse, France, under contract 21/PLER/TOU/IPBS01/20130042. According to articles L12434 and R124361 of the French Public Health Code, the contract was approved by the French Ministry of Science and Technology (agreement number AC 2009921). Written informed consents were obtained from the donors before sample collection.
Non-Human Primate (NHP) samples
All animal procedures were approved by the Institutional Animal Care and Use Committee of Tulane University, New Orleans, LA, and were performed in strict accordance with NIH guidelines. The twenty adult rhesus macaques used in this study (Table S1 and S2) were bred and housed at the Tulane National Primate Research Center (TNPRC). All macaques were infected as previously described (Foreman et al., 2016; Mehra et al., 2011; Souriant et al., 2019) . Briefly, aerosol infection was performed on macaques using a low dose (25 CFU implanted) of Mtb CDC1551. Nine weeks later, a subgroup of the animals was additionally intravenously injected with 300 TCID50 of SIVmac239 in 1mL saline, while controls received an equal volume of saline solution. Euthanasia criteria were presentation of four or more of the following conditions: (i) body temperatures consistently greater than 2°F above preinfection values for 3 or more weeks in a row; (ii) 15% or more loss in body weight; (iii) serum CRP values higher than 10 mg/mL for 3 or more consecutive weeks, CRP being a marker for systemic inflammation that exhibits a high degree of correlation with active TB in macaques (Kaushal et al., 2012; Mehra et al., 2011) ; (iv) CXR values higher than 2 on a scale of 0-4; (v) respiratory discomfort leading to vocalization; (vi) significant or complete loss of appetite; and (vii) detectable bacilli in BAL samples.
Bacteria
Mtb H37Rv strain was grown in suspension in Middlebrook 7H9 medium (Difco) supplemented with 10% albumin-dextrose-catalase (ADC, Difco) and 0.05% Twen-80 (Sigma-Aldrich) (Lastrucci et al., 2015) . For infection, growing Mtb was centrifuged (3000 RPM) at exponential phase stage and resuspended in PBS (MgCl2, CaCl2 free, Gibco). Twenty passages through a 26-G needle were done for dissociation of bacterial aggregates. Bacterial suspension concentration was then determined by measuring OD600, and then resuspended in RPMI-1640 containing 10% FBS for infection.
Viruses
Virus stocks were generated by transient transfection of 293T cells with proviral plasmids coding for HIV-1 ADA and HIV-1 NLAD8-VSVG isolates, kindly provided by Serge Benichou (Institut Cochin, Paris, France), as previously described (Verollet et al., 2015) . Supernatant were harvested 2 days post-transfection and HIV-1 p24 antigen concentration was assessed by a homemade enzyme-linked immunosorbent assay (ELISA). HIV-1 infectious units were quantified, as reported (Souriant et al., 2019) HIV-VLP stock (GFP VLP) was generated by transfecting the molecular clone pGag-eGFP obtained from the NIH AIDS Research and Reference Reagent Program. HEK-293 T cells were transfected with calcium phosphate (CalPhos, Clontech) in T75 flasks using 30 μg of plasmid DNA. Supernatants containing VLPs were filtered (Millex HV, 0.45 μm; Millipore) and frozen at −80°C until use. The p24 Gag content of the VLPs was determined by an ELISA (Perkin-Elmer).
Preparation of human monocytes and monocyte-derived macrophages
Human monocytes were isolated from healthy subject (HS) buffy coat (from EFS) and differentiated towards macrophages as described (Souriant et al., 2019) . Briefly, peripheral blood mononuclear cells (PBMCs) were recovered by gradient centrifugation on Ficoll-Paque Plus (GE Healthcare). CD14 + monocytes were then isolated by positive selection magnetic sorting, using human CD14 Microbeads and LS columns (Miltenyi Biotec). Cells were then plated at 1.6 x 10 6 cells per 6-well and allowed to differentiate for 5-7 days in RPMI-1640 medium (GIBCO), 10% Fetal Bovine Serum (FBS, Sigma-Aldrich) and human M-CSF (20 ng/mL) Peprotech) before infection with Mtb H37Rv for conditioned-media preparation. The cell medium was renewed every 3 or 4 days.
Preparation of conditioned media
Conditioned-media from Mtb-infected macrophages (cmMTB) has been reported previously (Lastrucci et al., 2015; Souriant et al., 2019) . Succinctly, hMDM were infected with Mtb H37Rv at a MOI of 3. After 18h of infection at 37°C, culture supernatants were collected, sterilized by double filtration (0.2µm pores) and aliquots were stored at -80°C. We then tested the capacity of individual cmMTB to differentiate freshly isolated CD14 + monocytes towards the M(IL-10) cell-surface marker phenotype, as assessed by FACS analyses. Those supernatants yielding a positive readout were then pooled together (5-10 donors) to minimize the inter-variability obtained between donors. Control media (cmCTR) was obtained from uninfected macrophages supernatant. When specified, IL-10 was eliminated from cmMTB by antibody depletion as described previously (Lastrucci et al., 2015; Souriant et al., 2019) . The depletion was verified by ELISA (BD-Bioscience), according to manufacturer's protocol.
Conditioning of monocytes with the secretome of Mtb-infected macrophages or cytokines
Human CD14 + sorted monocytes from HS buffy coat were allowed to adhere in the absence of serum (0.4 × 10 6 cells / 24-well in 500 µL) on glass coverslips, and then cultured for 3 days with 40% dilution (vol/vol) of cmCTR or cmMTB supplemented with 20% FBS and M-CSF (20 ng/mL, Peprotech). Blocking IFNAR receptor was performed by pre-incubation with mouse anti-IFNAR antibody (20 µg/mL, Thermo Fischer Scientific) in a 200 L for 30 min prior to conditioning. After 3 days, cells were washed and collected for phenotyping.
When specified, monocytes were also conditioned in presence of 20 ng/mL M-CSF and 10 ng/mL recombinant human IL-10 (PeproTech) or 10 U/mL of IFN (Peprotech). Cell-surface expression of Siglec-1 was measured by flow cytometry using standard procedures detailed hereafter.
RNA extraction and transcriptomic analysis
Cells conditioned with cmCTR and cmMTB supernatants (approximately 1.5 million cells) were treated with TRIzol Reagent (Invitrogen) and stored at -80°C. Total RNA was extracted from the TRIzol samples using the RNeasy mini kit (Qiagen). RNA amount and purity (absorbance at 260/280 nm) was measured with the Nanodrop ND-1000 apparatus (Thermo Scientific). According to the manufacturer's protocol, complementary DNA was then reverse transcribed from 1 µg total RNA with Moloney murine leukemia virus reverse transcriptase (Invitrogen), using random hexamer oligonucleotides for priming. The microarray analysis was performed using the Agilent Human GE 4x44 v2 (single color), as previously described (Lugo-Villarino et al., 2018) . Briefly, we performed hybridization with 2 g Cy3-cDNA and the hybridization kit (Roche NimbleGen). The samples were then incubated for 5 min at 65°C, and 5 min at 42°C before loading for 17h at 42°C, according to manufacturer's protocol. After washing, the microarrays were scanned with MS200 microarray scanner (Roche NimbleGen), and using Feature Extraction software, the Agilent raw files were extracted and then processed through Bioconductor (version 3.1) in the R statistical environment (version 3.6.0). Using the limma package, raw expression values were background corrected in a 'normexp' fashion and then quantile normalized and log2 transformed (Ritchie et al., 2015) . Density plots, boxplots, principal component analyses, and hierarchical clustering assessed the quality of the hybridizations. Differentially expressed genes between macrophages exposed to cmCTR or cmMTB supernatants were extracted based on the p-value corrected using the Benjamini-Hochberg procedure. The log2 normalized expression values were used to perform Gene Set Enrichment Analyses (GSEA). The GSEA method allows to statistically test whether a set of genes of interest (referred to as a geneset) is distributed randomly or not in the list of genes that were pre-ranked according to their differential expression ratio between macrophages exposed to cmCTR or cmMTB supernatants. The output of GSEA is a GeneSet enrichment plot. The vertical black lines represent the projection onto the ranked GeneList of the individual genes of the GeneSet. The top curve in green corresponds to the calculation of the enrichment score (ES). The more the ES curve is shifted to the upper left of the graph, the more the GeneSet is enriched in the red cell population. Conversely, the more the ES curve is shifted to the lower right of the graph, the more the GeneSet is enriched in the blue cell population.
siRNA silencing
Targets silencing in monocytes was performed using reverse transfection protocol as previously described (Troegeler et al., 2014) . Shortly, human primary monocytes were transfected with 200 nM of ON-TARGETplus SMARTpool siRNA targeting Siglec-1 (Horizon Discovery) or non-targeting siRNA (control) using HiPerfect transfection system (Qiagen). Four hours post-transfection, transfected cells were incubated for 24h in RPMI-1640 medium, 10% FBS, 20 ng/mL of M-CSF, before addition of cmMTB media (40% vol/vol). After 3 additional days, cells were infected with HIV-1 ADA or HIV-1-NLAD8-VSV-G strain and kept in culture for 10 more days (48h, respectively). As soon as 3-day post-transfection, this protocol led to the efficient depletion of Siglec-1 between a range of 50-95%, as measured by flow cytometry.
HIV-1 infection
For HIV-1 infection, at day 3 of differentiation, 0.4 x 10 6 human monocytes-derived macrophages (hMDM) were infected with HIV-1 ADA strain (or specified) at MOI 0.1. HIV-1 infection and replication were assessed 10-day post-infection by measuring p24-positive cells by immunostaining and the level of p24 released in culture media by ELISA. For the infection and TNT quantification at day 6 post-infection, the same protocol was used. For HIV-1 transfer, higher MOI of HIV-1 VSVG pseudotyped NLAD8 virus was used, as described below (see section HIV-1 and cell-to-cell transfer) and in (Souriant et al., 2019) .
Uptake of Virus-Like Particles
Uptake experiment were performed as previously described (Izquierdo-Useros et al., 2012a; Izquierdo-Useros et al., 2014; Pino et al., 2015) using p24 Gag HIV-1Gag−eGFP VLP (GFP VLP). Briefly, monocytes transfected or not with control siRNA or with siRNA directed against Siglec-1 and differentiated for 3 days in cmCTR or cmMTB were washed once with PBS prior to addition of 2 ng/mL of GFP VLP. Binding was performed during 3.5h at 37°C in a 5 % CO2 incubator. Cells were then detached with cell dissociation buffer (Gibco) and prepared for flow cytometry analysis on a BD LSRFortessa (TRI-Genotoul platerform). Same experiment was also performed blocking monocyte-derived macrophages at RT for 15 min with 10 μg/ml of mAb α-Siglec-1 7-239 (Abcam), IgG1 isotype control (BD Biosciences) or leaving cells untreated before VLP addition.
Flow cytometry and Siglec-1 quantitation
Staining of conditioned macrophages was performed as previously described (Souriant et al., 2019) . Adherent cells were harvested after 5 min incubation in trypsin 0.05% EDTA (Gibco) and washes with PBS (Gibco). After 10 min centrifugation at 320g, pellets were resuspended in cold staining buffer (PBS, 2mM EDTA, 0.5% FBS) with fluorophore-conjugated antibodies (See Table 1 ) and in parallel, with the corresponding isotype control antibody using a general concentration of 1 µg/mL. After staining, cells were washed with cold staining buffer, centrifuged for 2 min at 320g at 4°C, and analyzed by flow cytometry using BD LSRFortessa flow cytometer (BD Biosciences, TRI Genotoul plateform) and the associated BD FACSDiva software. Data were then analyzed using the FlowJo_V10 software (FlowJo, LLC). Gating on macrophage population was set according to its Forward Scatter (FSC) and Size Scatter (SSC) properties before doublet exclusion and analysis of the median fluorescence intensity (MFI) for each staining.
To determine Siglec-1 expression we applied a quantitative FACS assay. Briefly, cmCTR-and cmMTB-treated macrophages were detached using Accutase solution (Gibco) for 10 min at 37ºC, washed, blocked with 1 mg/mL human IgG (Privigen, Behring CSL) and stained with mAb 7-239 α-Siglec-1-PE or matched isotype-PE control (Biolegend) at 4°C for 30 min. The mean number of Siglec-1 mAb binding sites per cell was obtained with a Quantibrite kit (Becton Dickinson) as previously described (Izquierdo-Useros et. al 2012b) . Samples were analyzed with FACSCalibur using CellQuest software to evaluate collected data.
Immunofluorescence microscopy
Cells were fixed with PFA 3.7%, Sucrose 30 mM in PBS. After washing with PBS, cells were saturated with blocking buffer (PBS-BSA 1%). Membrane proteins were then stained for 2h with primary antibodies: anti-Siglec-1 (10 µg/mL, Novus Biologicals). Cells were then incubated with appropriate secondary antibodies for 1h: Alexa Fluor 488 or 555 or 647 Goat anti-Mouse IgG (2 µg/mL, Cell Signaling Technology). Cells were then permeabilized as previously described (Souriant et al., 2019) with Triton X-100 0,3% for 10 minutes, washed in PBS before saturation with 0.6 µg/mL mouse IgG2 diluted in Dako Antibody Reducing Background buffer (Dako) for 30 min. Intracellular proteins were then stained with anti-Gag KC57 RD1 antibody (1/100, Beckman Coulter) and/or anti--tubulin (5 µg/mL, Abcam) for 2h. Cells were washed and finally incubated with Alexa Fluor 488, 555 or 647 Goat anti-Mouse or Goat anti-Rabbit IgG secondary antibodies (2 µg/mL, Cell Signaling Technology), Alexa Fluor 488 or 555 Phalloidin (33 mM, Thermo Fisher Scientific), Wheat Germ Agglutinin (CF®350 WGA, Thermofischer) and DAPI (500 ng/mL, Sigma Aldrich) in blocking buffer for 1h. Coverslips were mounted on a glass slide using Fluorescence Mounting Medium (Dako) and visualized with a spinning disk (Olympus) ( Fig. S2C; 3A ; 3F; S3A, S3B, S3C; movie 1), a Zeiss confocal LSM880 with Airyscan ( Fig. 3D, Movie 2) and a FV1000 confocal microscope (Olympus) (Fig.  4F ).
TNT were identified by WGA or phalloidin and tubulin staining, and counted on at least 1000 cells per condition and per donor.
As HIV-1 infection induces macrophages fusion into MGC (Verollet et al., 2010) the number of infected cells largely underestimates the rate of infection. Thus, to better reflect the rate of infection, we quantified the percentage of multinucleated cells. Using semi-automatic quantification with homemade Image J macros, allowing the study of more than 5,000 cells per condition in at least five independent donors, assessed these parameters.
HIV-1 and cell-to-cell transfer
Freshly isolated CD14 + monocytes from HS transfected with siRNA against Siglec-1 or siRNA control were allowed to adhere in the absence of serum (2×10 6 cells/6-well in 1.5 mL). After 4h of culture, RPMI-1640 supplemented with 20 ng/mL M-CSF and 20% FBS were added to the cells (vol/vol). After 24h, cells were conditioned with cmMTB media. At day 4, 120 ng p24 of a HIV-1 NLAD8 strain pseudotyped with a VSVG envelope was used to infect half of the cells, kept in culture for 2 more days. At day 6, before co-culture, uninfected cells were stained with CellTracker Green CMFDA Dye (Thermo Fisher Scientific). For mitochondria transfer, half of the macrophages were pre-stained with Green CellTracker, and the other half, uninfected, was stained with mitoTracker Deep-Red prior to co-culture. Briefly, cells were washed with PBS Mg 2+ /Ca 2+ and stained for 30 min with 500 ng/mL CellTracker or mitoTracker, before washing with RPMI-1640 10% FBS. HIV-1 + or mitoTracker + and CellTracker + cells were then detached using accutase (Sigma) and co-cultured at a 1:1 ratio on glass coverslips in 24-well.
Histological analyses
Paraffin embedded tissue samples were sectioned and stained with hematoxylin and eosin for histomorphological analysis. Different antigen unmasking methods where used on tissue slides for immunohistochemical staining, which was performed using anti-CD163 (Leica/Novocastra), anti-Siglec-1 (Novus Biologicals) and anti-pSTAT1 (Cell Signaling Technology). Sections were then incubated with biotin-conjugated polyclonal anti-mouse or anti-rabbit immunoglobulin antibodies followed by the streptavidin-biotin-peroxidase complex (ABC) method (Vector Laboratories). Finally, sections were counter-stained with hematoxylin. Slides were scanned with the Panoramic 250 Flash II (3DHISTECH). Virtual slides were automatically quantified for macrophage distribution as previously described (Souriant et al., 2019) . Immunofluorescence staining of the sections was performed as described above and followed by anti-mouse IgG isotype specific or anti-rabbit IgG antibodies labelled with Alexa488 and Alexa555 (Molecular Probes). Samples were mounted with Prolong® Antifade reagent (Molecular Probes) and examined using a 60x/1.40N.A. objective of an Olympus spinning disk microscope.
Quantification and statistical analysis
Information on the statistical tests used and the exact values of n (donors) can be found in the Figure Legends . All statistical analyses were performed using GraphPad Prism 8.0.0 (GraphPad Software Inc.). Two-tailed paired or unpaired t-test was applied on data sets with a normal distribution (determined using Kolmogorov-Smirnov test), whereas two-tailed Mann-Whitney (unpaired test) or Wilcoxon matched-paired signed rank tests were used otherwise. p<0.05 was considered as the level of statistical significance (* p≤0.05; ** p≤0.005; *** p≤0.0005; **** p≤0.0001). Figure S3 ).
Figure 4. TB-driven exacerbation of HIV-1 infection and spread in macrophages requires
Siglec-1 (see also Figure S4 ). (A) Experimental design. Monocytes from healthy subjects were transfected with siRNA targeting of Siglec-1 (siSiglec-1, black) or not (siCtrl, white). A day after, monocytes were differentiated into macrophages with cmMTB for 3 days. Cells were then infected with HIV-1-ADA (blue protocol) to measure the formation (B) and length (C) of TNT at day 7, or assess HIV-1 production and multinucleated giant cell (MGC) formation at day 14 (F-G) . In parallel, cells were either infected with HIV-NLAD8-VSVG or labelled with mitoTracker to measure the transfer (red protocol) of HIV-1 (D) or mitochondria (E), respectively. 
